Which class of anti-hypertensives is commonly associated with compliance issues among patients?

ACE inhibitors are commonly associated with compliance issues among patients due to several factors. One of the primary reasons is the side effects that some individuals experience when taking these medications. Common side effects include a persistent cough, which can be bothersome enough to lead patients to discontinue treatment. Additionally, ACE inhibitors can cause elevated potassium levels and issues with kidney function, leading to further monitoring and potential adjustments in therapy, which can affect patient adherence.

Patient education also plays a significant role in compliance. ACE inhibitors require understanding how they work and the importance of ongoing monitoring, which can sometimes be overwhelming for patients. The necessity for regular blood tests to check kidney function and electrolyte levels can also discourage consistent use.

In contrast, although other classes like beta-blockers, calcium channel blockers, and angiotensin receptor blockers can also face compliance challenges, ACE inhibitors have particularly notable issues due to the side effects and required monitoring. Understanding these factors is crucial for managing patient expectations and improving adherence to antihypertensive therapy.